Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0KG1T
|
|||
Drug Name |
Pyrimido-indole derivative 2
|
|||
Synonyms |
PMID26924192-Compound-81
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
|
|||
Structure |
Download2D MOL |
|||
Formula |
C26H29N7O2
|
|||
Canonical SMILES |
CCN1C(=C2CCCCC2=N1)NC3=NC(=NC4=C3C5=CC(=C(C=C5N4)C6=C(ON=C6C)C)OC)C
|
|||
InChI |
1S/C26H29N7O2/c1-6-33-26(16-9-7-8-10-19(16)31-33)30-25-23-17-12-21(34-5)18(22-13(2)32-35-14(22)3)11-20(17)29-24(23)27-15(4)28-25/h11-12H,6-10H2,1-5H3,(H2,27,28,29,30)
|
|||
InChIKey |
PKOGGTPBCXRZNX-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Bromodomain and extraterminal domain protein (BET) | Target Info | Inhibitor | [1] |
Target's Patent Info | Bromodomain and extraterminal domain protein (BET) | Target's Patent Info | [1] | |
KEGG Pathway | SNARE interactions in vesicular transport | |||
Reactome | COPII (Coat Protein 2) Mediated Vesicle Transport | |||
WikiPathways | miR-targeted genes in squamous cell - TarBase | |||
miR-targeted genes in muscle cell - TarBase | ||||
miR-targeted genes in lymphocytes - TarBase |
References | Top | |||
---|---|---|---|---|
REF 1 | BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.